Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma
Hepatobiliary Surg Nutr
.
2023 Dec 1;12(6):923-926.
doi: 10.21037/hbsn-23-476.
Epub 2023 Nov 15.
Authors
Rita Khoury
1
,
Nadine Khalife
2
,
Rebecca Ibrahim
1
,
Khalil Saleh
1
Affiliations
1
International Department, Gustave Roussy Cancer Campus, Villejuif, France.
2
Head and Neck Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
PMID:
38115933
PMCID:
PMC10727814
DOI:
10.21037/hbsn-23-476
No abstract available
Keywords:
Futibatinib; RLY-4008; cholangiocarcinoma; infigratinib; pemigatinib.
Publication types
Editorial
Comment